| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.034 | 0.8 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |